Hildebrandt, Per

2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 4,763

Defibrillator implantation in patients with nonischemic systolic heart failure

Køber, L., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., Jensen, G., Hildebrandt, P., Steffensen, F. H., Bruun, N. E., et al. (2016) · New England Journal of Medicine

Cardiac pacing and defibrillation studiesCardiac Arrest and Resuscitation

Cited by 1,763

Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity

Malmberg, K., Rydén, L., Wedel, H., Birkeland, K., Bootsma, A., Dickstein, K., Efendic, S., Fisher, M., Hamsten, A., Herlitz, J., et al. (2005) · European Heart Journal

Hyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Treatment and Management

Cited by 1,048

Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure

Kistorp, C., Faber, J., Galatius, S., Gustafsson, F., Frystyk, J., Flyvbjerg, A., & Hildebrandt, P. (2005) · Circulation

Heart Failure Treatment and ManagementAdipokines, Inflammation, and Metabolic Diseases

Cited by 605

Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial

Poole-Wilson, P. A., Lubsen, J., Kirwan, B.-A., van Dalen, F. J., Wagener, G., Danchin, N., Just, H., Fox, K. A., Pocock, S. J., Clayton, T. C., et al. (2004) · The Lancet

Heart rate and cardiovascular healthCoronary Interventions and Diagnostics

Cited by 511

Risk prediction is improved by adding markers of subclinical organ damage to SCORE

Sehestedt, T., Jeppesen, J., Hansen, T. W., Wachtell, K., Ibsen, H., Torp-Petersen, C., Hildebrandt, P., & Olsen, M. H. (2010) · European Heart Journal

Cardiovascular Health and Disease PreventionHealth Promotion and Cardiovascular Prevention

Cited by 315

Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure

Gustafsson, I., Brendorp, B., Seibæk, M., Burchardt, H., Hildebrandt, P., Køber, L., & Torp-Pedersen, C. (2004) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 258

Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: Experiences from MERIT-HF

Deedwania, P. C., Giles, T. D., Klibaner, M., Ghali, J. K., Herlitz, J., Hildebrandt, P., Kjekshus, J., Spinar, J., Vitovec, J., Stanbrook, H., et al. (2005) · American Heart Journal

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 143

Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria

G�de, P., Hildebrandt, P., Hess, G., Parving, H.-H., & Pedersen, O. (2005) · Diabetologia

Heart Failure Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 105

Cardiovascular Events in Thyroid Disease: A Population Based, Prospective Study

Schultz, M., Kistorp, C., Raymond, I., Dimsits, J., Tuxen, C., Hildebrandt, P., & Faber, J. (2011) · Hormone and Metabolic Research

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 67

Amino-terminal pro-B-type natriuretic peptide testing to assist the diagnostic evaluation of heart failure in symptomatic primary care patients

Hildebrandt, P., & Collinson, P. O. (2008) · The American Journal of Cardiology

Heart Failure Treatment and ManagementCardiac Fibrosis and Remodeling

Cited by 50

Prevalence and characteristics of diabetic patients in a chronic heart failure population

Kistorp, C., Galatius, S., Gustafsson, F., Faber, J., Corell, P., & Hildebrandt, P. (2005) · International Journal of Cardiology

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 33